Chronic lymphocytic/lymphoma panel
General information
Panel of markers used: CD3, CD5, CD19, CD23,
CD79b, Kappa chains, Lambda chains, FMC7, CD38 (optional markers:
CD10, CD11c, CD25, CD103).
Specimen transport: At room temperature in EDTA
tube.
Repeat frequency: Post treatment monitoring,
suspected relapse and MRD
Special precautions: Do not refrigerate
Laboratory information
Reporting units: Percentage of the population
of cells of interest
Volume and sample type: 5mls EDTA blood or bone
marrow
Method: Flow cytometry
Turnaround time (calendar days from sample
receipt to authorised result): Median - 2, 95th percentile - 7
Clinical information
Indications for the test: Haematological
malignancies involving lymphoid cells
Factors affecting the test: None
Clinical workstation reference: PHENOTYPING
(Last updated October 7th
2014)